10/01/2025
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has again been named to the Top 100 Women-Led Businesses in Massachusetts. The annual list is compiled by The Women’s Edge in partnership with The Boston Globe Magazine. Fresenius Medical Care ranked #4 – as it did in 2024.
Helen Giza, CEO and Chair of the Management Board, continues to lead the company’s strategic realignment under the FME Reignite strategy, which will guide Fresenius Medical Care’s direction and innovation in kidney care for the coming years. In 2024, Fresenius Medical Care received FDA clearance for the 5008X™ CAREsystem, enabling hemodiafiltration (HDF) therapy in the United States for the first time. The company continues the rollout of the 5008X in the U.S. for the commercial rollout in 2026. This advancement introduces our patients in the U.S. to a new treatment that has demonstrated promising results in Europe and other regions, including reduced hospitalization rates and lower mortality rates.
FME has achieved a global Patient Net Promoter Score of 72, reflecting strong patient trust and satisfaction across care settings. The company is uniquely positioned in the industry as the only dialysis provider with a successful vertically integrated structure that combines services and medtech.
The Women’s Edge is a Boston-based nonprofit organization that supports women leaders across industries. This year marks the 25th anniversary of its Top 100 list, which recognizes organizations making a measurable impact on the Massachusetts economy through leadership, innovation, and performance. Rankings are based on revenue, diversity, and other key metrics.
The ranked list was revealed at the Women’s Edge awards breakfast on Friday, October 24, and published in the October 26 edition of the Boston Globe’s Women & Power magazine. The full list can be viewed here.